BB Pureos Bioventures

Investor type

VC / CVC

Founded

2020

AUM

-

Location

Switzerland

$0-1 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Investor profile last updated: 06 December, 2025

Profile

STRATEGY
Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats. We strive to impact patients’ lives by advancing innovative treatments for severe diseases.

PORTFOLIO
Our companies are developing innovative therapeutics for severe diseases and contitions. We are backing great teams with development programs that make a true difference for patients.

TEAM
We are career venture capitalists, biotech founders, former pharma and biotech executives, research scientists, medical doctors, and experienced drug developers. What unites us is the passion for biotech start-ups, innovation and the quest for new and better medicines.

Industry

Healthcare Services HealthTech Biotechnology Pharmaceuticals

Region of investment

North America Europe

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
Ar2TmGFQahXwopu4 Ar2TmGFQahXwopu4
Ar2TmGFQahXwopu4
avatar
Ar2TmGFQahXwopu4 Ar2TmGFQahXwopu4
Ar2TmGFQahXwopu4
avatar
Ar2TmGFQahXwopu4 Ar2TmGFQahXwopu4
Ar2TmGFQahXwopu4
avatar
Ar2TmGFQahXwopu4 Ar2TmGFQahXwopu4
Ar2TmGFQahXwopu4
avatar
Ar2TmGFQahXwopu4 Ar2TmGFQahXwopu4
Ar2TmGFQahXwopu4
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about BB Pureos Bioventures

BB Pureos Bioventures is located in Switzerland.
BB Pureos Bioventures was founded in 2020.
BB Pureos Bioventures invests in companies and startups in Healthcare Services, HealthTech, Biotechnology, Pharmaceuticals.
BB Pureos Bioventures invests in companies and startups in North America, Europe.
BB Pureos Bioventures invests in companies and startups at Seed, Series A.
BB Pureos Bioventures usually invests $0-1 m on average.